Literature DB >> 6459992

Lipopolysaccharide-induced activation of suppressor cells: reversal by an agent which alters cyclic nucleotide metabolism.

R A Winchurch, C Hilberg, W Birmingham, A M Munster.   

Abstract

The effects of bacterial lipopolysaccharides (LPS) on the suppressor activity of mouse spleen cells were examined. Pretreatment with LPS was shown to induce suppressor activity in vivo and in vitro. Concurrent treatment of spleen cells with LPS and imidazole, an agent which increases the activity of cyclic nucleotide phosphodiesterases and hastens the degradation of cyclic AMP, reversed the suppressor-inducing effects of LPS. In vitro treatment of spleen cells with aminophylline, an agent which inhibits phosphodiesterase activity, had no effect on suppressor activity. The reversal of LPS-induced suppressor activity by imidazole was time-dependent and addition of this agent 20 hr after LPS treatment did not reverse suppression. These data are consistent with the hypothesis that LPS-induced suppressor activity may be mediated via cyclic AMP-dependent pathways.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6459992      PMCID: PMC1555153     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Lipopolysaccharide-induced suppression of the primary immune response to a thymus-dependent antigen.

Authors:  U Persson
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

2.  The control exerted by thymic hormone (THF) on cellular cAMP levels and immune reactivity of spleen cells in the MLC assay.

Authors:  A I Kook; N Trinin
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

3.  Differential effects of cholera toxin pre-treatment on in vitro vs. in vivo immunocyte responses.

Authors:  S F Lyons; H Friedman
Journal:  Proc Soc Exp Biol Med       Date:  1978-04

4.  Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides.

Authors:  J Andersson; O Sjöberg; G Möller
Journal:  Eur J Immunol       Date:  1972-08       Impact factor: 5.532

5.  The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes.

Authors:  D L Peavy; W H Adler; R T Smith
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

6.  Bacterial lipopolysaccharides activate immune suppressor cells in newborn mice.

Authors:  R A Winchurch; C Hilberg; W Birmingham; A M Munster
Journal:  Cell Immunol       Date:  1981-03-01       Impact factor: 4.868

7.  Bacterial lipopolysaccharide activates suppressor B lymphocytes.

Authors:  S Koenig; M K Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

8.  In vitro generation of nonspecific suppressor cells and their characterization.

Authors:  A Anaclerio; M L Moras; C Honorati; A Ruggeri; G Conti; F Spreafico
Journal:  Transplantation       Date:  1979-05       Impact factor: 4.939

9.  The involvement of cyclic nucleotide metabolism in the initiation of lymphocyte proliferation induced by mitogens.

Authors:  J Watson
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

10.  Plaque Formation in Agar by Single Antibody-Producing Cells.

Authors:  N K Jerne; A A Nordin
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

View more
  3 in total

1.  Increases in the numbers of immunoglobulin-secreting cells in lymph nodes responding to sperm and other stimuli: possible relationship to immunosuppression.

Authors:  R J Hancock; A M Popham; S Faruki; D W Dresser
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

2.  Mitogenic activities of synthetic lipid A analogs and suppression of mitogenicity of lipid A.

Authors:  K Tanamoto; C Galanos; O Lüderitz; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

3.  Cyclic AMP inhibition of lipopolysaccharide-induced restriction of Legionella pneumophila growth in macrophage cultures.

Authors:  K Egawa; T W Klein; Y Yamamoto; C A Newton; H Friedman
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.